Training Programs Accordions
Currently listing programs from Beth Israel Deaconess Medical Center, Boston University, Brigham & Women's Hospital, Brown University, The Children's Hospital of Philadelphia, Columbia University, Harvard Medical School, Icahn School of Medicine at Mount Sinai, The Johns Hopkins University, University of Massachusetts, University of Pittsburgh, Schepens Eye Institute, Temple University and Yale University
Currently listing programs from Emory University, Louisiana State University, Medical University of South Carolina, North Carolina State University, University of Alabama School of Medicine, University of Kentucky, University of Mississippi Medical Center, University of North Carolina, University of Texas, University of Texas Southwestern Medical Center, University of Virginia, Virginia Commonwealth University, Vanderbilt University and Wake Forest University
Director and Contact:
W. Robert Taylor, MD, PhD
Division of Cardiology
Emory University School of Medicine
Program Scope and Mission – We are recruiting postdoctoral research trainees to work in the laboratories of investigators in the Division of Cardiology at Emory University School of Medicine. Several positions are available in basic science and translational laboratories within the Division. All projects involve animal and cell-based model systems to study vascular biology or cardiovascular disease. Trainees will be responsible for designing, conducting and presenting research, as well as participating in appropriate training, seminars and symposiums as required.
Successful candidates will have a strong publication record in peer reviewed journals and a long-term goal of becoming an independent investigator. Due to grant funding restrictions, candidates must meet the following two criteria to be considered: hold a MD, PhD or equivalent degree AND be a United States citizen or green card holder.
Viola Vaccarino, MD, PhD.
Wilton Looney Chair of Cardiovascular Research
Professor and Chair, Dept. of Epidemiology
Rollins School of Public Health
Professor, Dept. of Medicine, School of Medicine
Steven Harris, Program Administrator
Department of Epidemiology
Emory University Rollins School of Public Health
1518 Clifton Rd. NE
Atlanta, GA 30322
Program Scope and Mission – The Department of Epidemiology at the Rollins School of Public Health, Emory University, is seeking pre- and postdoctoral fellows for a NHLBI-funded training grant (T32) in cardiovascular diseases. The program focuses on broadly defined inequalities in cardiovascular health, including, among others, factors such as race/ethnicity, sex/gender, socioeconomic status, and geographical residence.
Housed in the Department of Epidemiology, the training program is affiliated with several other departments and schools including Public Health, Cardiology, Medicine, Nursing, and the Morehouse School of Medicine. The program combines training in graduate degree programs in the Rollins School of Public Health with multidisciplinary research experiences working with top investigators in cardiovascular sciences from diverse disciplines, from basic sciences to epidemiology, cardiology, genetics, interventions, and health policy. The training follows a mentor-based model with formal didactic work in areas relevant to research in cardiovascular health inequalities (e.g., statistics, epidemiology, social determinants of health, and cardiovascular physiology), and practical training in grantsmanship, research ethics, and career development. Predoctoral Fellows:
· Will be considered among those accepted in the RSPH’s PhD programs: http://www.sph.emory.edu/academics/doctoral-programs/index.html
· Program covers tuition and stipend while in the fellowship program. Postdoctoral Fellows:
· MDs from various backgrounds pursuing a research career in cardiovascular disease, or PhD graduates in epidemiology, behavioral sciences, environmental sciences, health policy, or other relevant disciplines.
· Opportunity to obtain a MS in Clinical Research.
· Program covers stipend for up to two years. Criteria for appointment to the training program will include academic potential, previous experience, research interest in cardiovascular health inequalities, and compatibility with existing mentors. Only U.S. citizens and permanent U.S. residents are eligible for this program.
Dr. Donald Menick, Ph.D.
Director, Gazes Cardiac Research Institute
Professor of Medicine
Professor of Biochemistry & Molecular Biology
Director, Molecular & Cellular Biology & Pathology Program
Dr. Donald Menick, Ph.D.
Department of Medicine, Division of Cardiology
Medical University of South Carolina
Gazes Cardiac Research Institute
114 Doughty Street, Room 203
Charleston, SC 29403
Program Scope and Mission – Research at the Medical University of South Carolina (MUSC) has rapidly developed over the past 25 years and cardiovascular biology has been a major focus of resource commitment. For FY2011 MUSC investigators received more than $12.7 million of research funding from the NHLBI alone. Since the beginning of this training program in 1977, there has been and continues to be a strong emphasis on the molecular and structural aspects of the entities involved in cellular dysfunction in cardiovascular disease. MUSC provides an exciting environment for creative, committed investigators and trainees interested in cardiovascular function in health and disease.
Postdoctoral and predoctoral positions are supported by the National Institute of Heart, Lung and Blood training grant "Training to Improve Cardiovascular Therapies". Our objective is the training of promising new scientists with backgrounds in physical, chemical and biomedical sciences in mechanisms of cardiovascular diseases and the experimental strategies and technologies necessary for the development of novel molecular therapeutics targeting these diseases. Our aim is to produce outstanding investigators with broad insight into cardiovascular biology and dysfunction capable of making significant contributions to cardiovascular research. Faculty in the training program come from five broad research areas: 1) Molecular basis of cardiovascular development, 2) Mechanisms of cardiovascular development, 3) Cardiac stem cells and regenerative medicine and bioengineering, 4) Cell signaling, and 5) Proteomics. Our faculty is highly interactive in both predoctoral and postdoctoral training, and our postdoctoral students benefit in many ways from an organized graduate program in cardiovascular biology.
Dr. Marie Davidian, Ph.D.
J. Stuart Hunter Distinguished Professor
Program Co-Director, NHLBI Integrated Biostatistical Training Program for CVD Research
Program Scope and Mission – The shortage of skilled biostatisticians equipped to address emerging challenges in this exciting new era of CVD research calls for training that formally integrates (i) in-depth experience in collaboration in a multidisciplinary environment, (ii) mastery of the theoretical underpinnings of statistics required for valid application of sophisticated biostatistical techniques and research on development of new methodology, and (iii) emphasis on communication and leadership skills. The program capitalizes on the long-standing partnership between NCSU and Duke, which provides trainees with the opportunity for outstanding theory and methods training and to work with internationally-known researchers at the forefront of CVD research. Trainees will develop all of these skills through interaction with faculty at both universities, who themselves have a history of inter-institutional collaboration and research and who have extensive experience in training and mentoring.
The training involves formal coursework in the student's home department on foundational statistical theory, including probability, inference, linear and other statistical models, measure theory and advanced probability, and advanced statistical inference; and on statistical methods, including clinical trial design/analysis, longitudinal data analysis, survival analysis, epidemiology, causal inference, machine learning, and high-dimensional data analysis; and exposure at DCRI to fundamental aspects of CVD medicine, working with large, complex biomedical data, and research responsibility and ethics considerations. There is also extensive formal and experiential training in communication and leadership skills at both institutions. Trainees are introduced to DCRI CVD research gradually and will evolve over their tenures to holding substantial collaborative apprenticeships in which they are fully integrated as functioning members of DCRI project teams. The apprenticeships will provide trainees with extensive working knowledge of CVD research, the opportunity to develop collaborative skills, and the recognition of how new biostatistical methods development follows from challenges encountered in the collaborative context. This last point will be emphasized through mechanisms under which statistical methodological challenges arising in trainees' apprenticeships will lead to doctoral dissertation research in biostatistics.
Director and Contact:
Phillip J. Brantley, PhD
Associate Executive Director For Scientific Education
Pennington Biomedical Research Center/LSU
6400 Perkins Road
Baton Rouge, Louisiana 70808-4124
Program Scope and Mission – Pennington Biomedical Research Center in Baton Rouge, Louisiana invites applications for postdoctoral fellowships on their NCCIH Institutional Training. We are seeking MDs or PhDs with biomedical research experience who are interested in conducting basic research into obesity, diabetes, and the use of botanicals to attenuate metabolic syndrome. Eligible Applicants must be a US citizen or green card holder. Evidence of motivation and skills in scientific writing such as publications and grant experience are highly desirable. Fellowships provide up to three years of funding, and include didactic instruction and mentored laboratory based training necessary to establish an independent research career. http://www.pbrc.edu/training-and-education/postdocs/botanical-approaches-to-combat-metabolic-syndrome/
Jack M. Rogers, PhD
Professor, Department of Biomedical Engineering
Co-Director Jianyi Zhang, MD, PhD
Professor and Chair, Department of Biomedical Engineering
Jack M. Rogers
University of Alabama at Birmingham
School of Medicine Dept. of Biomedical Engineering
1670 University Blvd
Birmingham, Alabama 35233
Program Scope and Mission – Cardiovascular tissue engineering (CVTE) has tremendous, but as yet unrealized, potential to treat disease. Future scientists and engineers working in this area will need expertise in a broad range of subfields including cardiovascular pathophysiology, cell/scaffold engineering methods, and the diverse technologies needed to evaluate the electromechanical safety and efficacy of prototype therapies. To help meet this need, the NIH National Institute of Biomedical Imaging and Bioengineering (NIBIB) has awarded UAB a new Ruth L. Kirschstein NRSA Institutional Research Training Grant (T32). The five year grant, titled “Development and Functional Assessment of Cardiovascular Tissue Engineering Therapy,” will be co-directed by BME Chair Jay Zhang and myself. The program will support up to four predoctoral students per year drawn from UAB’s Biomedical Engineering and Graduate Biomedical Sciences programs. The new program builds on research strengths in CVTE-related fields in the BME department and across UAB. We are excited and thankful for the new support from NIH and look forward to training a cadre of professionals in academia, government, and industry who will accelerate the safe clinical adoption of CVTE technology.
Nancy R Webb, PhD
T32 Program Director
Department of Pharmacology and Nutritional Sciences
Director, Division of Nutritional Sciences
535 Wethington Health Sciences Building
Lexington, KY 40536-0200
Phone: (859) 218-1385
Program Scope and Mission – An NIH-funded T32 training grant entitled “Pharmacology and Nutritional Sciences: Multidisciplinary Approaches for Metabolic Disease” is housed in the Department of Pharmacology and Nutritional Sciences, Division of Nutritional Sciences at the University of Kentucky. The training grant seeks to prepare biomedical scientists for academic careers in research focused on pharmacological and nutritional approaches to prevent and treat metabolic-based disorders. The training faculty come from 8 different departments in 4 Colleges across the University of Kentucky campus. They have expertise in the four theme areas of the training grant: obesity/diabetes, cardiovascular disease, cancer, and neuroscience/aging.
Susan Smyth, M.D., Ph.D.
Chief, Division of Cardiovascular Medicine
Linda and Jack Gill Heart and Vascular Institute
Director, MD/PhD Program
326 CTW Building 900
900 south Limestone Street
Lexington, Kentucky 40536-0200
Website: Clinical Scholars in Cardiovascular Science
Leigh Ann Callahan, M.D.
Program Scope and Mission – The University of Kentucky Training Program for Clinical Scholars in Cardiovascular Science is designed to prepare exceptional clinical and postdoctoral fellows to assume leadership positions directing multidisciplinary research in the field of cardiovascular medicine. In the last several years, as a consequence of substantial institutional commitment, we have assembled an integrated approach of incorporating basic, translational and clinical cardiovascular science in four concentrations: Thrombosis and Inflammation; Atherosclerosis and Aneurysm; Cardiac Hypertrophy and Heart Failure; and Vascular Cell Response to Stress. Our cardiovascular science strengths to provide a unique multidisciplinary training program that unites trainees across the disciplines of Medicine, Nursing, and Pharmacy with the goal of increasing the pipeline of clinical investigators who will bridge the gap between basic science advances and their application to clinical medicine. Specifically, we aim to:
1) To provide a rigorous and solid research education in the basic sciences related to cardiovascular research
2) To prepare new researchers for translational and clinical science in a highly interdisciplinary environment
3) To provide training in the efficient and ethical conduct of high quality laboratory management and science
4) To create an environment that incubates fellows and mentors with an innovative and nurturing structure of interlaced mentoring teams
The program is available to M.D., M.D./Ph.D., R.N./Ph.D., Pharm.D., and Ph.D.s with clinical emphasis who are at the early post-doctoral stage of their careers. Upon completion of the program, we anticipate that the trainees will have the experience and capabilities necessary to initiate an independent career as clinical investigator.
Joey P. Granger, PhD
Director of Research Operations
MS Center for Clinical and Translational Research
University of Mississippi Medical Center
Program Scope and Mission – UMMC has identified hypertension and cardiovascular and renal diseases as a major area for research development in its strategic research plan. The institution has made a significant commitment to basic and clinical cardiovascular and renal research and the training of students and fellows at both the pre-doctoral and postdoctoral level. Additionally, UMMC is committed to training students and fellows that are members of under-represented racial and ethnic minorities.
There are several key features of this program:
· Long history of cardiovascular and renal disease research and training at UMMC;
· Only extramurally funded institutional training grant at UMMC;
· Multidisciplinary instruction through a core curriculum and an interdepartmental research center (CRRC) that focuses on hypertension and cardiovascular-renal diseases research;
· Required application for independent pre-doctoral and postdoctoral funding for all trainees;
· Requirement to develop an individual development plan (IDP);
· Unique Career Opportunities and Profession Development (COPD) seminar series for trainees to learn about wide range of career opportunities;
In response to the recent NIH Biomedical Research Workforce report, alternative career modules (teaching, business, and pharma/biotech) for trainees to expand their training experiences are provided;
Outstanding institutional support where Graduate School provides:
· 3 years of stipend support for graduate students
· Full tuition scholarships for all PhD students
· Trainee travel program provides up to $1,500 per academic year for PhD trainees presenting their research at a conference. Graduate students who are awarded an individual extramural fellowship grant are also eligible to receive an additional travel stipend of $1,500 to present their research findings at a national meetings. · Professional skills travel program provides up to $1,500 per academic calendar year for PhD graduate students to attend one workshop, review course, etc. per academic year.
Kari North, PhD
Professor and Program Director
Department of Epidemiology
University of North Carolina
137 East franklin Street Suite 306
Chapel Hill, NC 27599
Program Scope and Mission – Human genome studies are providing fresh insights into heart, lung, and blood (HLB) traits, with opportunities for translation of research findings to clinical and community settings for disease prevention and health promotion. Yet, there remain an insufficient number of HLB genetic epidemiologists who can design and implement multidisciplinary HLB genetic epidemiology research that combines technological advances in genome measurement with cutting-edge statistical tools to advance understanding of the genomic basis of HLB traits and associated diseases in the most-burdened populations.
The Genetic Epidemiology of Heart, Lung, and Blood Traits (or GenHLB) Training Grant responds to these research gaps by providing interdisciplinary, integrated, and comprehensive instruction in the genetic epidemiology of HLB traits from an outstanding team of research mentors with expertise spanning four proposed training dimensions: HLB genetic epidemiology; computation/methods; `OMICs; and culture, diversity, and disparities. The Training Program will encompass formal didactics based on an individual development plan; tailored mentorship; research experiences in two training dimensions; presentations; manuscript and grant preparation; research seminars and colloquia; and instruction in the responsible conduct of research. The GenHLB training program also will include careful evaluation of the quality and effectiveness of the Training Program, ensuring that fellows achieve the competencies and skills necessary for success as future HLB genetic epidemiology research leaders.
The five-year program aims to support four (two pre-doctoral and two postdoctoral) fellows at initiation, increasing to six (three pre-doctoral and three postdoctoral) fellows in year 03. Among the postdoctoral fellows, prior expertise in epidemiology, human genetics, biostatistics, bioinformatics, computational biology, medicine, and applied mathematics will be sought. Pre-doctoral fellows will be required to pursue a doctoral degree in epidemiology, specializing in HLB genetic epidemiology. Our selection of internationally known research mentors with established research collaborations, unique and multidisciplinary training environment, and unparalleled research opportunities make us exceptionally well-positioned to lead this novel training program and develop the next generation of genetic epidemiology leaders who are well-equipped to investigate the genetic underpinnings of HLB traits and associated diseases.
Christopher Mack, Director
Associate Professor of Pathology
University of North Carolina
111 Mason Farm Road
Suite 2341 MBRB
Chapel Hill, NC 27599
Contacts & Grants Facilitator
Program Scope and Mission – In response to the demands of the post-genomic era, we established the Integrative Vascular Biology (IVB) Pre-doctoral Training Program at the University of North Carolina in 2002 to promote a collaborative interdisciplinary training environment for pre-doctoral students in the cardiovascular field. The IVB Program was founded on the breadth and depth of the cardiovascular research faculty at UNC and institutional strengths in genetic model systems, state of the art cell biology and imaging, high throughput genomic and proteomic analyses, and computational biology. The overall goal of the IVB Program is to provide Trainees with the interdisciplinary and collaborative skills necessary to extend their thesis work into new, innovative, and productive directions. Our primary training faculty are drawn from 12 UNC departments and have specific expertise in heart and blood vessel development, thrombosis and hemostasis, the mechanisms that contribute to atherosclerosis, and the pathophysiology and treatment of myocardial ischemic disease. By requiring trainees to collaborate with secondary mentors outside of their Field, Department, and/or Institution, the program teaches students to apply molecular, cellular, genetic, and computational approaches to pathological and physiological questions in cell, organ, and whole animal systems; to merge hypothesis- and discovery-based research; to develop high-throughput approaches in cardiovascular models, and to translate their work to clinical settings.
Trainees are exposed to the latest concepts in cardiovascular biology by enrolling in advanced paper-based courses specifically designed for UNC's Graduate Certificate Program In Cardiovascular Science, by attending formal cardiovascular seminars by inside and outside speakers, and by participating in a bi-weekly student-led discussion group. To enhance the skills necessary for effective collaboration and career advancement, Trainees attend program workshops on grant writing, career development, and scientific rigor and responsibility, and they present their data formally at the annual IVB Research Symposium, a trainee-organized event that draws over 120 cardiovascular researchers from the greater Chapel Hill area. In summary, with an outstanding history in cardiovascular research, a strong, well-funded group of investigators centered around the McAllister Heart Institute, a structured academic program in Cardiovascular Science, and institutional excellence in genetic model systems, cell biology, high throughput sequencing, and computational biology, the UNC Integrative Vascular Biology Program offers an outstanding environment for multidisciplinary training of pre-doctoral students. For more information, please contact program Director Christopher Mack.
Dr. Kytai T. Nguyen
The University of Texas at Arlington
Science & Engineering Innovation & Research Building, SEIR-367
655 W. Mitchell St.
Arlington, TX 76010
Program Scope and Mission – Nanotechnology and nanomedicine have been developed and used to detect and improve the treatment efficacy for many diseases, including cardiovascular and lung disorders. However, only a few doctoral programs exist to train doctoral (Ph.D.) students to have a background of strong, basic health and translational science in conjunction with new advances in nanotechnology and nanomedicine applied to cardiovascular and lung diseases. To bridge the gap, our long-term objective of this NIH T32 training program is to train doctoral students in North Texas in the principles, advances, opportunities and limitations of nanomaterials, nanomedicine and nanotechnology for use in the detection and treatment of cardiovascular and lung diseases. To reach our objective, we will provide an integrative nanotechnology training program, enhance trainees’ expertise and knowledge in broad-based nanotechnology areas, and achieve outstanding program outcomes in order to raise up the next generation of nanotechnology leaders.
Director and Contact:
Dr. James D. Stockand, PhD
University of Texas Health Science Center
Department of Cellular and Integrative Physiology -7756
7703 Floyd Curl Drive, MSK 7756
San Antonio, TX 78229
Program Scope and Mission – Cardiovascular disease complications remain the major leading cause of death and disability in the United States and other developed countries. While lifestyle clearly contributes to the development of cardiovascular disease, it has not proven realistic to expect resolution of major morbidities (and attenuate costs) simply on the basis of changes in lifestyle. Consequently, biomedical science must continue to address improvements in the prevention, diagnosis and treatment of the widespread and devastating complications of cardiovascular disease. To achieve this goal, a cadre of well-trained, multidisciplinary scientists, capable of working in investigative teams, is required. This postdoctoral research training program enables the continued achievement of excellence in research training in cardiovascular pathobiology by preparing new investigators with the necessary competencies and breadth of expertise needed for future biomedical research.
This is a multi-disciplinary postdoctoral research training program in cardiovascular science that annually supports six doctoral graduate fellows in medicine, dentistry, veterinary medicine, or the basic biomedical sciences. Program faculty are distributed among twelve academic departments at the University of Texas Health Science Center at San Antonio, and two departments at nearby sister institutions, the University of Texas at San Antonio and the Southwest National Primate Research Center.
Lance Terada, MD
Professor and Chief
Pulmonary and Critical Care
Philip Shaul, MD
Vice Chair for Research
Professor and Chief
Pulmonary and Vascular Biology
Lance Terada, MD
Program Scope and Mission – This program provides structured research training opportunities at the postdoctoral level with support for two years of training. The proposal is born out of a collaborative effort between divisions within the Pediatric and Internal Medicine departments involved in lung and vascular research at this institute, and is thus interdepartmental at its core. Our training faculty consist of experienced investigators representing 16 different clinical and basic science departments and centers, forming a solid, diverse training force, organized into four thematic tracks: 1) Pulmonary vascular disease; 2) Interstitial lung diseases; 3) Lung epithelial cell and differentiation disorders; and 4) Immunity/Inflammation/Sepsis. Besides mentor-based teaching, trainees will receive a comprehensive track- and project-specific didactic curriculum. Both clinical and basic science trainees will be guided by an individualized advisory committee that has both basic and clinical science mentors, to broaden the trainee’s perspective and facilitate bench to bedside thinking. Emphasis will be placed on maintenance of project focus, creative experimental design, state of the art technology, and careful early career guidance.
Director and Contact:
Mark D. Okusa, MD
1300 Jefferson Park Avenue
West Complex, Room 5097B
University of Virginia Health System
Charlottesville, VA 22908–0133
Program Scope and Mission – Kidney disease is a major health problem for both adults and children. Renal diseases of various etiologies continue to grow at a rate of epidemic proportions. Furthermore there is a diminishing “pipeline” of nephrology trainees leading to a lack of new discoveries, cures and clinical trials in the kidney research arena. It is imperative that we meet this challenge and ensure the training of a new cadre of outstanding investigators in kidney-related research. The goals of the program are to identify promising candidates and train them for careers in academic nephrology. We have assembled an exemplary team of clinician and basic science investigators with an outstanding track record of mentorship from various Departments and Centers including: Medicine, Pediatrics, the Pediatric Center of Excellence in Nephrology, Pharmacology, Microbiology, Molecular Physiology and Biophysics, Biomedical Engineering, the Cardiovascular Research Center, Surgery, the Beirne Carter Center of Immunology and Public Health Sciences. The basic/translational faculty laboratories offer research experience that links kidney development, cell fate, and disease with inflammation. The program provides training and didactic instruction in fundamental and cutting-edge methodologies, including novel molecular, cellular, transgenic and imaging technologies, as well as immunology, functional genomics and novel imaging technologies. The patient- oriented clinical research program provides training in clinical investigation, epidemiology, biostatistics and human genetics. Three new mentors in genetic susceptibility to kidney disease and disease progression have been recruited. Adult and Pediatric Nephrology trainees with M.D. degrees will pursue a program consisting of 1 year of clinical training, which is not supported by the grant, and 2-3 years of research training funded by this application. PhD applicants will be required to have prior research experience and outstanding references. Each of the thirty-four mentors/co-mentors has a track record of mentorship and is an expert in one or more core areas that pertain to kidney development and disease and inflammation including: kidney development and disease pathogenesis, diabetes/vascular disease, cell signaling, leukocyte biology and patient-oriented research/genetic epidemiology. All trainees will be required to attend regular seminars, journal clubs and specific courses addressing research methodologies, experimental design, research integrity, ethics and faculty development, in addition to. Newly designed translational programs are aimed to link clinical disease with basic science. They will be expected to design, conduct, and analyze experiments with progressive independence in our new, modern, and well-equipped laboratories. We value and encourage applicants from diverse academic and ethnic backgrounds. It is the goal of the mentored training program that its graduates attain a strong foundation in translational biomedical research and be among a new generation of academic nephrologists and renal investigators who will make significant contributions in addressing the growing problem of kidney disease in the adult and pediatric populations.
Gary K. Owens Ph.D.
Programs Administrator/Administrative Generalist
Robert M. Berne Cardiovascular Research Center
415 Lane Road (MR5) PO Box 801394
Charlottesville, Va. 22908
Program Scope and Mission – Despite decades of research there are still fundamental gaps in our knowledge of the underlying mechanisms that contribute to development and progression of most cardiovascular diseases (CVD), as well as the end stage clinical consequences of these diseases and how to better treat or prevent them. Indeed, CVD remains the leading cause of death worldwide. A central premise of our NIH T32 cardiovascular (CV) research training program (CVTP) is that these diseases are extremely complex, and that rigorous study of them requires trainees to have a strong foundation of knowledge of basic CV physiology, developmental biology, genetics, genomics, bioinformatics, epigenetics, pathology, systems biology, biomedical engineering, and many other disciplines. A major strength of our CVTP is that we have >50 outstanding clinical, translational, and basic science mentors representing all of these areas, and we have built a unique training program over the past three decades that integrates mentoring talents into producing the best trained cardiovascular scientists possible. Our goal is to provide pre-doctoral and post-doctoral trainees the necessary knowledge, intellectual capabilities, technical skills, and problem-solving abilities to conduct outstanding state-of-the-art CV research employing a wide range of powerful and innovative approaches.
The program is led by Dr. Gary K. Owens and two talented Associate Directors Drs. Brant Isakson and Shayn Peirce-Cottler who are exceptional CV researchers and mentors. Pre-doctoral trainees are selected from a large pool of outstanding trainees initially recruited into an umbrella biomedical sciences (BIMS) graduate program http://bims.virginia.edu/ or the UVA MD/PhD (NIH MST) Program https://mstp.med.virginia.edu/, whereas post-doctoral candidates are largely recruited by individual mentor labs or from one of several clinical residency-fellowship programs. After completing a highly innovative BIMS 6000 core course in integrated biology in year 01, CVTP pre-doctoral trainees take elective modular courses that are customized based on their interests and degree program. They also complete three lab rotations to aid in selection of a mentor. Only trainees who have already selected a CVTP mentor are eligible for appointment to our NIH T32 training grant. All trainees are required to take our signature CVTP advanced courses including BIMS 8052-3 (Advanced Vascular Biology) and BIMS 8064 (a trainee-run Careers/Professionalism Course), and are also required to attend our weekly research seminars, monthly research in progress sessions, bi-annual research retreats, and to complete biomedical ethics training. The CVTP also has an exceptional grant writing program including an annual workshop and approximately 20 annual grant brewing sessions.
There are many indices of the success of this program including CVTG trainees: 1) publishing many high impact first author papers including in some of the highest rated biomedical journals such as Nature, Nature Medicine, and Circulation Research; 2) having a >50% success rate in securing extramural fellowships upon first submission; 3) securing high quality post-doctoral, or faculty/leadership positions, at major academic medical centers, in the pharmaceutical industry, or with biotechnology companies; and 4) making extraordinary contributions advancing our understanding of the cardiovascular system, as well as developing better ways to treat or prevent CVD.
Irving L. Kron, M.D.
Professor and Chair of Surgery
Division of Thoracic and Cardiovascular Surgery
Tony Herring, Laboratory Manager
P.O. Box 801359
Bldg MR4, Rm 3116
409 Lane Road
Charlottesville, VA 22908
Office: 434-924-9297 Fax: 434-924-1218
Victor E. Laubach, PhD
Professor of Surgery
Office: 434-924-2927 Fax: 434-924-1218
Program Scope and Mission – Our TCV Surgery Research Training Program has been continuously funded since 2000 by an NIH T32 Training award with Dr. Irving Kron as the Principle Investigator. This training program provides collaboration between basic scientists and surgical faculty to train academic cardiothoracic surgeons. The main objective of our program is to provide surgery residents with hypothesis-driven research training in laboratory or clinical research in order to foster their development into independent academic translational researchers. Translational research defines the area of overlap between basic and clinical studies, where new therapies, interventions, assays, etc. are brought out of the laboratory for human benefit. The primary discipline which our program focuses on is translational research into vascular and end-organ function following transplantation or surgery.
Christopher M. Kramer, M.D.
Ruth C. Heede Professor in Cardiology
Director, Cardiovascular Imaging Center
Cardiovascular Imaging Fellowship Coordinator
UVA Division of Cardiovascular Medicine
1215 Lee Street, Room 2772
PO Box 800662
Charlottesville, VA 22908
Program Scope and Mission – UVA’s advanced fellowship in cardiovascular imaging trains fellows in the use of cutting-edge technology that in turn facilitates a better understanding of the mechanisms of heart disease and of cardiac physiology and pathophysiology.
Specific program goals include:
- providing competence in technical aspects of imaging;
- providing competence in cardiac physiology and pathophysiology;
- studying and developing innovative methods of imaging The Advanced Cardiovascular Imaging Fellowship Program is supported by a training grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB).
Dr. Greg Hundley
Pauley Heart Center
Program Scope and Mission – The Pauley Heart Center is seeking candidates for a postdoctoral training program in cardiovascular disease research. This 3 year individually-tailored training program offers a stipend and tuition reimbursement for a VCU Masters in Clinical Health Science program, or other VCU master’s degree program. In addition, travel funds to present at a scientific conference as well as funds for health insurance expenses.
Research opportunities may include laboratory-based, translational and clinical projects, may involve animal or human subjects and relate to cardiovascular disease. Some areas of interest include (but are not limited to):
- Cardiotoxicity related to cancer therapy
- Role of inflammation in acute myocardial infarction and heart failure
- Cardiovascular pathophysiology in the context of metabolic disease
- Mechanisms of myocardial protection in ischemia/reperfusion injury
- Mitochondrial biology as it relates to heart injury and the aged heart
- Nanoengineering novel platforms for therapeutic delivery of miRNA in cardiopulmonary disease
- Molecular and cellular mechanisms of electrical remodeling in diseased hearts
- Development of computational models to study electrical signaling in cardiac electrophysiology
- Preventive cardiology
- Social and behavioral determinants of cardiovascular events
- The impact of obesity in cardiovascular disease
Candidate should have a PhD, MD/PhD or equivalent degree by the start of the fellowship and a commitment to a career in cardiovascular medicine. In addition, candidate should have demonstrated experience working in and fostering a diverse faculty, staff, and student environment or commitment to do so as a postdoc at VCU. MUST have a green card or US citizenship.
Dr. C. Michael Stein, M.B., Ch.B.
Dan May Professor of Medicine and Pharmacology
C. Michael Stein, M.B., Ch.B.
542 Robinson Research Building
Program Scope and Mission – Vanderbilt’s Clinical Pharmacology Fellowship Program is a highly successful program that has produced graduates who are now in prominent positions in academia, industry and regulatory agencies. Our training program is registered with the American Board of Clinical Pharmacology and thus trainees are eligible to sit for the board exam.
The training period is at least 2 years, preferably more, and is weighted towards learning through mentored research. In addition, formal coursework and directed learning provide education in core skills. Trainees include individuals with an M.D., Ph.D. or Pharm.D. degree who are planning a career in clinical pharmacology or a career that will be strengthened by significant exposure to clinical pharmacology. A large and diverse faculty in the division, the rich resources at Vanderbilt and our commitment to training has established the outstanding reputation of this Clinical Pharmacology Fellowship Program. Continued excellence of the program depends on our fellows and we invest heavily in their training.
Randi Sullivan, MD, MHS
Wake Forest University School of Medicine
Department of Internal Medicine
Section on Cardiovascular Medicine
Medical Center Boulevard
Winston-Salem, NC 27157
Program Scope and Mission – The purpose of the CVD Epidemiology Training Program, a federally-funded National Research Service Award (NRSA) Institutional Research Training Grant (2 T32 HL076132), is to attract and train a cohort of outstanding physician scientists who will be fluent in the latest developments in cardiovascular disease and able to apply this knowledge to the conduct of new cardiovascular epidemiology and clinical cardiovascular research. Key features of the training program include completion of a Master’s Degree in Clinical and Population Translational Science with a curriculum that also includes formal training in molecular biology and genetics, supplemental training in genomics, proteomics and informatics, joint mentorship with both clinical and basic science faculty, and participation in external NHLBI sponsored short courses in cardiovascular epidemiology, and the genetics of complex heart, lung, and blood disorders.
Currently listing programs from BloodCenter of Wisconsin, Northwestern University, Ohio State University, University of Cincinnati, University of Illinois at Chicago, University of Iowa, University of Michigan, University of Minnesota, University of Missouri, University of Wisconsin, Wayne State University, and Washington University Medical School.
Gilbert C. White, II, MD
Attn: Portlynne Joseph/T32 Postdoc
Blood Research Institute
PO Box 2178
Milwaukee, WI 53201-2178
Program Scope and Mission – Research opportunities available to trainees cover a broad range of basic and clinical research subjects relevant to transfusion medicine and hematology; including; Immunology, Vascular Biology/Hemostasis, Transfusion Medicine, Stem Cell Biology, and Clinical Research. The research training experience will be essentially full time. Trainees will be expected to gain a basic understanding of the disciplines in which they undertake their investigations, develop competency with a variety of research technologies, strengthen their grasp of their chosen research by taking selected courses in the graduate studies program of Medical College of Wisconsin, and develop the ability to conduct independent research. Time spent in fellowship training is regarded as one of several stages of professional development. Accordingly, additional tracks will be offered to selected trainees including; the opportunity 1) to apply for a Clinical Investigator Development Award (K08) for continued mentoring, 2) to apply for independent grant support, and 3) for those oriented toward a career in transfusion medicine, an opportunity for further training as a junior member of BloodCenter's medical staff. Ultimately, trainees are expected to pursue academic or alternate careers in transfusion medicine, hematology, or closely related fields.
Karin Hoffmeister, M.D.
Senior Investigator Blood Research Institute
Professor of Biochemistry at Medical College of Wisconsin
Associate Professor of Pediatrics, Harvard Medical School
K12 Program Administrator
BloodCenter of Wisconsin
Blood Research Institute
8733 W. Watertown Plank Rd.
Wauwatosa, WI 53226
Phone: (414) 937-6896
Program Scope and Mission – Translational medicine fosters cross-functional collaborations between researchers and clinicians to facilitate new and precision-driven treatments for individualized therapy. While scientists and clinicians successfully applied this approach to four fundamental building blocks of life (nucleic acids, lipids, proteins and carbohydrates), the science of glycans (carbohydrates) has received the least attention. The diverse functions of glycans contribute to the structural integrity of biomolecules, extracellular matrix formation, signal transduction, protein folding, information exchange between cells, and host-pathogen interactions. Despite their functional diversity and specificity, carbohydrates are commonly associated with weight gain and diabetes while their major contributions to health and disease remain vastly understudied. Furthermore, the use and modulation of glycans has been largely unexplored in therapeutic strategies. There is an urgent need to support and educate glycoscientists concomitantly with the biology of human health and disease, thus enabling clinicians and glycoscientists to recognize medical needs and therapeutic opportunities. To meet these needs, the National Heart, Lung, and Blood Institute (NHLBI) for the first time has offered a K12 Career Development Program in translational glycosciences titled “National Career Development Consortium for Excellence in Glycosciences.”
One of the four national sites is the Blood Research Institute and the Center for Translational Glycomics, BloodCenter of Wisconsin (BCW), in association with the Medical College of Wisconsin (MCW), Roswell Park Comprehensive Cancer Center (Roswell), and Virginia Commonwealth University (VCU). This program, The Medical and Translational GlycOmics Program (Translational GlycO Program), is a multi-institution (Wisconsin, New York and Virginia) program, linking unique and diverse glycoscience expertise with research facilities, major teaching hospitals, blood banking and pharmaceutical education. It is expected that the Translational GlycO Scholars will commit to and pursue a glycoscience based investigation, as it relates to the mission of the NHLBI (heart, blood, lung, and sleep disorders). Training in investigative glycoscience thought processes and experimental tools will be provided through a rigorous program involving hands-on research, didactic coursework, collaboration with experienced scientists in and outside the field, dissemination of knowledge, paper and grant writing activities, and participation in the national K12 consortium. Scholars will become knowledgeable in 1) molecular aspects of glycoscience; 2) experimental research inquiries into functions of glycans; 3) translation of bench research to the bedside; 4) dissemination of research to scientists and the lay public; and 4) writing extramurally funded grant applications. For more information and application processes refer to the K12 Program Website
Ivor Benjamin, M.D., F.A.H.A., F.A.C.C.
Director, Cardiovascular Center
Professor, Department of Medicine
Froedtert & Medical College of Wisconsin
MCW Cardiovascular Center
Medical College of Wisconsin
8701 Watertown Plank Rd.
Milwaukee, WI 53226
(414) 955-5611 | Fax (414) 456-6515
Program Scope and Mission –
This five year T32 program is one of only six post-doctoral T32 training programs on the Milwaukee Medical Regional Campus. The grant provides up to three-years of training for post-doctoral fellows with an MD, PhD, PharmD, or DO degree (two new slots/year). Forty-six basic scientists and translational investigators serve as mentors in a program that is supported by specific research areas of scientific excellence (“Signature Programs”), a highly-integrated collaborative research environment, and access to an extensive research infrastructure.
This three-year training commitment emphasizes critical components designed to launch/sustain research careers: • Individualized development plans (IDPs), • Personalized multidisciplinary mentoring teams, • Training in core competencies, and • Industry/biotechnology or scientific liaison career options for trainees not pursuing a traditional career in academia. Overall, the ultimate goal of this training program is to train the next generation of cardiovascular scientists, including underrepresented minorities, by incorporating broad-based, personalized, supportive, and rigorous training opportunities. Additional support for trainees is provided by a grant from the A. O. Smith Foundation for the Cardiovascular Center’s A. O. Smith Fellowship Scholars Program. This unique program is designed to support talented cardiovascular researchers and physicians in an innovative educational program that aims to provide mentoring, training, research support, and the necessary resources to overcome the barriers that exist to launching and sustaining a successful research career.
Mark K. Eskandari, MD, F.A.C.S.
The James S. T. Yao, MD, PhD, Professor of Vascular Surgery
Chief and Program Director, Division of Vascular Surgery
Feinberg School of Medicine
676 N. St. Clair, #650
Chicago, IL 60611
Marsha Blunt, VSSTP Program Coordinator
Telephone: (312) 926-7775
Northwestern Email: email@example.com
Program Scope and Mission –
The NIH-funded Vascular Surgery Scientist Training Program at Northwestern University is a two-year mentored research training program designed for surgical residents (MD/DO) in general, cardiac, and vascular surgery interested in vascular biology or vascular biomedical engineering careers. Our goal is to provide a seamless multidisciplinary environment in which the trainee may interact with a diverse group of distinguished research faculty. The T32 mechanism provides a stipend, tuition, fees for coursework, travel funds, and health insurance.
The key to this program is an individualized training plan developed by the mentor and trainee. The unique multidisciplinary environment provides trainees with opportunities to work with mentors from different disciplines. The goal of this program is to match the research interest of the trainee to mentors, coursework, seminars, meetings, and a research plan that will collectively provide the experience necessary to launch a successful career as a physician scientist. Trainees may select one of several tracks of study or a combination of tracks:
• Vascular biology with a basic science or translational emphasis,
• Clinical outcomes/health services research
• Biomedical devices in partnership with the Biomedical Engineering Department
• An integrated program designed by the trainee and his/her mentors.
Trainees who select the clinical outcomes/health services research track will pursue the Master of Science in Health Services and Outcomes Research degree program at NU.
Candidates must hold either an MD or DO degree and must have completed at least two years of clinical training prior to enrolling in the program. Candidates must be U.S. citizens, noncitizen nationals, or have been lawfully admitted for permanent residence at the time of appointment. Minorities and women are encouraged to apply. Applicants will submit a written application along with three letters of recommendation.
Dr. Vidu Garg
Dr. Peter Mohler
Program Scope and Mission – A postdoctoral fellow position is available for the T32 Fellowship Program entitled, “Training in Congenital and Acquired Heart Disease.” The program is jointly hosted by the Research Institute at Nationwide Children’s Hospital and the Dorothy M. Davis Heart and Lung Research Institute at The Ohio State University (PIs: Dr. Vidu Garg and Dr. Peter Mohler).
Eligibility requirements are as follows:
• MD, PhD, MD/PhD, DO, DVM, or PharmD, particularly underrepresented minorities, are encouraged to apply. Applicants will receive stipend (at appropriate NIH stipend guidelines), benefits and tuition support.
• Applicant must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence at the time of appointment.
• Proposed research must be directly related to aspects of congenital or acquired cardiovascular disease and can be basic, translational, clinical or outcomes research.
• 1 year fellowship that is renewed based upon productivity (for a maximum of 2 years).
• Applicants are required to participate in the T32-developed curriculum (i.e. didactic coursework, seminars and/or journal clubs).
• Applications are scored in 3 areas: trainee qualifications, scientific merit and training potential.
James K. Liao, MD
Harold H. Hines Professor, Committee on Molecular Metabolism and Nutrition
Chief, Department of Medicine – Section of Cardiology
Director, Physician Scientist Development Program
Phetcharat Chen, Administrator
Program Scope and Mission – The Cardiovascular Training Grant supports both post-doctoral (M.D. and Ph.D.) and pre-doctoral (Ph.D.) students for terms of 2-3 years to work in the laboratories of one of 33 trainers, whose research is in the cardiovascular sciences. The trainers include faculty from Cardiology, Pathology, Internal Medicine, Neurology, Pharmacology and Physiology, and Biochemistry and Molecular Biology. The program emphasizes training in vascular biology, atherosclerosis, cardiac development, cellular electrophysiology, cellular metabolism, cell signaling, gene regulation, and genetic disease.
Director and Contact:
Jeffery D Molkentin, PHD
Children's Hospital Medical Center-Cincinnati
Office of Sponsored Programs
3333 Burnet Avenue, MLC #7030
Cincinnati, OH 45229
Program Scope and Mission – The University of Cincinnati and Children’s Hospital is carrying on a proud tradition of excellence in cardiovascular research and mentorship, which began 35 years ago under Dr Arnold Schwartz as one of the longest training programs in cardiovascular. Our current collective 19 faculty has placed 297 of their past trainees into academics over their careers, 154 of whom have run, or currently run independent research programs. The overall scientific emphasis of our training program will continue to build from a basic platform of cardiovascular physiology, cell biology, biochemistry and pharmacology, but will also incorporate the latest approaches in the post genomic era, as well as incorporating clinical and translational approaches. The cardiovascular environment at Cincinnati Children's and the University of Cincinnati is considered one of the very best in the country, with 19 NIH funded faculty (some 49 NIH grants amongst them as PI status), 166 collaborative papers published in 10 years, and the very latest technologies and approaches with outstanding core support. The leadership consists of the co-PIs Drs. Evangelia Kranias and Jeffery D. Molkentin, both of whom have a long standing track record of working closely together (15 years), as well as having excellent mentorship credentials. The training grant funds 3 pre- and 3 postdoctoral trainees. Predocs are selected by the Internal Advisory Committee from a wide pool arising from departmental graduate programs, while postdoctoral candidates are selected based on being accepted into a mentor's laboratory and then passing the screening process by the Internal Advisory Committee and co-PIs. The training program also has an educational core where both pre-docs and post-docs take elective classes in cardiovascular biology, genetics, statistics, grant writing and ethics in research. More importantly, the cardiovascular training faculty at the University of Cincinnati and Children’s Hospital is one of the largest groups in the nation and they incorporate the very latest technologies in the pursuit of their scientific endeavors. Strengths include generation of transgenic and gene-targeted mice, as well as CRISPR-mediated mouse production, in the pursuit of understanding single gene function in complex cardiovascular diseases. Genetics are also employed and the program also has a strong clinical mentorship track for trainees interested in translational science.
mporary and a defined period (2-year) of mentored advanced training and professional development following completion of a doctoral degree program.
Asrar B. Malik PhD
Dr. Asrar B. Malik
Director of Center for Lung and Vascular Biology
University of Illinois College of Medicine
Department of Pharmacology
835 South Wolcott Ave, E403 MSB
Chicago, IL 60612
Phone: 312 996-5672
Program Scope and Mission – The NIH-funded UIC vascular biology training program is currently in its 25th year, providing comprehensive and cutting-edge training in vascular biology. Research topics include mechanisms of vascular regeneration, the use of stem cell therapies in vascular disease, the critical role of the vasculature in inflammation and immunity, modeling inherited vascular diseases with induced pluripotent stem cells, vascular biology of cancer, mechanisms of thrombosis and novel therapeutic anti-thrombotics. Our post-docs and PhD students are trained in using state-of-the art technologies such as intravital two-photon microscopy, super-resolution microscopy, protein engineering, high throughput small molecule screening or single cell transcriptomics. The training involves acquiring a range of skills from critical thinking and developing an innovative, testable hypothesis to deploying and utilizing relevant methods and technologies. We also offer opportunities to learn how to best communicate ideas and results through presentations and manuscripts. The success of our trainees is evident from their publication records in top tier journals and their current positions in academia and industry.
We have 40 preceptors participating in the training program who exhibit a breadth of scientific expertise ranging from basic cell biology to translational models of vascular disease. The faculty comprises a cohort of exceptionally talented mentors with a commitment to research training, collaboration, and developing careers of young investigators. These trainees and faculty meet regularly at the weekly vascular biology seminar as well as additional departmental seminars with invited speakers, many of whom are renowned leaders in the field of vascular biology. The program has several defining features that:
· contemporary biomedical research training must be underpinned by collaboration that can be local or international,
· research training is driven by fundamental ideas, and
· solving important scientific problems and research training should be such as to provide a variety of opportunities beyond the training phase.
The research training program provides opportunities for exposure to scientific leaders and role models and the intellectual environment of Chicago. It is our view that nurturing curiosity is a fundamental aspect of research training but that it also involves learning to ask important questions and becoming a well-rounded and humane individual.
Jan Kitajewski, PhD
Kishore Wary, PhD
Kamil Czarnowski, MPA
Director of Administrative Operations
Physiology and Biophysics
College of Medicine
University of Illinois at Chicago
835 South Wolcott Ave
Room E-231 MSB
Chicago, IL 60612
Program Scope and Mission – The NIH-funded Vascular Biology, Signaling and Therapeutics (VBST) training program is designed to be interdisciplinary, drawing on institutional expertise in four themes: Angiogenesis & Regeneration, Vascular Signaling, Neurovascular Biology and Vascular Therapeutics. VBST is made up of twenty-six (26) mentors, of which nine (9) are physician-scientists. This training program utilizes expertise within and interactions between the themes to train predoctoral and postdoctoral applicants in an integrative fashion.
VBST strives to meet an imperative need to train exceptionally talented and diverse scientists engaged in interdisciplinary vascular research with translational potential. The program’s aims are to assure that trainees understand the human vascular system, and are thereby poised to advance translational opportunities, reduce vascular disease, and bridge the current gaps in knowledge between discovery research, drug development and therapy.
Director and Contact:
Dawood Darbar, MBChB, MD
Program Scope and Mission – Project Summary Cardiovascular disease (CVD) remains a major cause for significant morbidity and mortality in the U.S. especially in ethnic minorities with their high burden of risk factors. Personalized medicine is a rapidly growing field of healthcare whereby an individual's unique genomic, environmental and clinical background is analyzed to ascertain susceptibility to disease, predict their clinical course and tailor specific therapies. Despite recent advances in CV genomics, our inability to target therapy to underlying mechanisms in individual patients, the failure to translate these scientific discoveries to the bedside care of patients and barriers to the incorporation of ethnic minorities in translational CV research have limited our ability to fulfill the promise of personalized medicine. Furthermore, traditional training programs are no longer able to provide trainees with the requisite skills needed to implement the personalized medicine revolution underway. Thereby, major goals of the Training Program in Personalized Cardiovascular Medicine (TPIPCVM) are to equip trainees to become leaders in CV Genomics and be trained in molecular, cellular, disease and whole animal modeling and clinical and translational approaches to CVD so that this new knowledge can be translated into best evidence-based personalized CV care. We will recruit highly talented and motivated pre- and post-doctoral trainees and provide them with the highest caliber training in CV genomics stemming from existing strengths of our faculty in the Division of Cardiology and our partners at UIC. The 3 Research Focus Groups: 1) Cardiac arrhythmias; 2) Ischemic and non-ischemic cardiomyopathy; and CVD-related metabolic syndrome are highly interrelated with each other and directly linked with the central theme of Personalized CV Genomics. The overarching goal of the TPIPCVM is to train the next generation of CV investigators to create new knowledge and implement into best evidence-based personalized medicine. The TPIPCVM mentors are highly successful physician-scientists/scientists with a proven record of research, mentoring and collaboration who offer superb inter- and multi- disciplinary training opportunities. Major strengths of this training program include: exposure of trainees to an integrated basic science molecular, cellular, and whole patient approach to identify the underlying mechanisms of CVD; the track record of the faculty and their common research interest in Personalized CV Genomics; dedicated training in personalized CV medicine; and the potential to implement scientific discoveries to a diverse and under-represented population of patients cared for at UIC Medical Center. The TPIPCVM sets out to train 2 pre-doctoral and 2 post-doctoral students annually. Collectively, this Training Program offers a unique training experience and fulfills an urgent need for training in personalized CV medicine.
Public Health Relevance
The Training Program In Personalized Cardiovascular Medicine (TPIPCVM) provides support for the training of basic and physician-scientists before and after their doctoral degrees. The central theme of the training program is cardiovascular genomics with a focus on abnormal heart rhythms (arrhythmias), weakened heart muscle (cardiomyopathies) and heart disease related the being overweight (metabolic syndrome) and how we can translate these discoveries to the bedside care of patients. The program will prepare future researchers for the unique challenges associated with treating patients with heart disease in an individualized manner.
Director and Contact:
Martha L. Daviglus, M.D., Ph.D.
Adjunct Professor of Preventive Medicine and Medicine
Executive Director, Institute for Minority Health and Research
Associate Vice Chancellor for Research
Program Scope and Mission – This Training Program is designed to prepare the next generation of scientists to conduct research in the epidemiology and prevention of cardiovascular disease (CVD) and related chronic diseases in minority populations. Despite decades of research progress, the burden of CVD and related chronic diseases in the United States remains high. Moreover, there are persistent race/ethnic disparities in CVD and other chronic disease outcomes. The goal of this program is to generate a talented and well-trained group of pre- and post-doctoral (MD and PhD) researchers to improve understanding of the etiology and prevention of CVD and related chronic conditions in minority populations and to alleviate race/ethnic disparities in CVD and related chronic disease outcomes.
Francois M. Abboud, M.D.
Edith King Pearson Chair of Cardiovascular Research
Associate Vice President for Research
Chair Emeritus, Department of Internal Medicine
Founding Director, Francois M. Abboud Cardiovascular Research Center
Professor of Internal Medicine – Cardiovascular Medicine
Professor of Molecular Physiology and Biophysics
Program Scope and Mission – The discovery of the causes of cardiovascular disease and their prevention; the care of the suffering patients and their cure, requires dedicated physicians and scientists to devote their lifelong work to a health mission without which a civilized society would not survive. Such individuals require years of training in medical science beyond their professional degree under the tutelage and mentoring of established senior medical investigators/teachers working in an environment with exceptional intellectual, technical, and physical resources. At the University of Iowa Cardiovascular Research Center, we have provided a world-renowned training center since 1975, have graduated hundreds of scientists, many of whom are national leaders throughout the USA, and aim to continue to do so for future generations with the renewal of federal support that we are applying for and hope to attain.
Jordan Shavit, M.D., Ph.D.
Henry and Mala Dorfman Family Professor of Pediatric Hematology/Oncology
Associate Professor of Pediatrics
University of Michigan
Program Scope and Mission – The Boxer Training Program in Molecular and Translational Hematology is designed to prepare physicians and postdoctoral scientists for independent, research-oriented careers in hematology. The program draws on the research interests and expertise of 19 well-funded faculty members in the Departments of Pediatrics, Internal Medicine, Pathology, Pharmacology, Cell and Developmental Biology, Molecular and Integrative Physiology, and Biological Chemistry, the Life Sciences Institute and the Howard Hughes Medical Institute, and the Schools of Engineering and Public Health at the University of Michigan. Active areas include molecular, cellular, and translational research of: 1) the pathophysiology of the immune system; 2) normal and malignant hematopoiesis; 3) hemostasis, thrombosis, and vascular biology; 4) blood and marrow transplantation; and 5) erythrocyte physiology and disease. A Selection/Monitoring Committee will recruit MD, MD/PhD, and PhD trainees with strong academic credentials who desire a scholarly career encompassing hematology teaching and research. MD candidates will have had 3 years of house officer training in Pediatrics or Internal Medicine and a year of clinical training in Pediatric or Adult Hematology/Oncology. PhD candidates will have a major interest in hematology-related research. Trainees spend 2-3 years under supervision of a faculty mentor, developing expertise in posing feasible scientific questions, acquiring skills to answer these questions, and critically evaluating data obtained. During their research training, trainees are continuously mentored and evaluated semiannually by a Mentoring Committee. Trainees present the results of their investigations, participate in discussions of data obtained by their colleagues, and attend relevant research seminars and interact with faculty members in basic and translational sciences. This program will fulfill a critical need to train the next generation of academic hematologists who will bridge the gap between laboratory and clinical research.
Daniel Michele, PhD
Professor, Departments of Molecular and Integrative Physiology and Internal Medicine
University of Michigan
North Campus Research Complex
2800 Plymouth Road, Bldg 26, Room 207S
Ann Arbor, MI 48109-2800
Program Scope and Mission – Cardiac and vascular diseases remain the leading causes of death worldwide, and the demand for a diversely trained PhD workforce to develop new therapies is expanding. The program goal is to address this deficit in the PhD workforce by teaching the next generation of cardiovascular PhD scientists and engineers how to develop and translate basic research towards applications in clinical medicine. This Predoctoral Training Program includes training on how to conduct preclinical translational research, improve understanding of steps of developing therapies from bench to bedside, and experiential learning in research entrepreneurship. All training is conducted at state of the art facilities of the Frankel Cardiovascular Center laboratories alongside world leading research teams in basic and translational research, clinical research, health services and outcomes research, and multidisciplinary programs.
The Program Features Include:
Basic Cardiovascular Research Training
- Selection of Research Training Mentor & Project and Perform Laboratory Research
- Selection of Clinical Advisor for your Project
- Frontiers in Cardiovascular Sciences Seminar Series
- Research Responsibility and Ethics Training
Training in Pre-Clinical Translational Research
- Pre-clinical Cardiovascular Models, Preclinical Testing and Phenotyping
- Translational Cardiovascular Research Seminars
Training in Research Entrepreneurship
- Research Entrepreneurship Bootcamp
- Entrepreneurship Course
- Experiential Learning in Project Design, Management and Team Science
Fellows are encouraged to explore a variety of additional enrichment activities to supplement the requirements of the training grant.
Aaron R. Folsom, M.D., M.P.H.
Professor, Division of Epidemiology and Community Health
Aaron R. Folson, M.D., M.P.H.
1300 S 2nd St
Room 300 West Bank Office Building
Minneapolis, MN 55454
Program Scope and Mission – While the rate of deaths from cardiovascular disease (CVD) has been on the decline, improved survival has resulted in significant new cases and cost to the health care system in our rapidly aging society. Thus the goal of CVD epidemiology is to investigate and promote cardiovascular health, and to prevent and reduce CVD.
Traditionally, cardiovascular disease epidemiology has been concerned with causes of heart disease. In recent years, prevention by modification of lifestyle and behavior have been tested and found very effective. In addition, new methods to detect disease while subclinical have strengthened our studies of antecedent risk factors. Researchers at EpiCH investigate the distribution and causes of CVD and study the influence of:
• high blood cholesterol
• high blood pressure
• blood clotting
• genetic variants
• obesity and weight gain
• fat distribution/ patterning They also explore the impact of health behaviors such as:
• physical inactivity
• psychosocial stressors
• geocoding and neighborhoods
Prof. Bob Tranquillo
Prof. Victor Barocas
Program Scope and Mission – The proposed T32 training program is designed uniquely to educate, train, and experientially sharpen doctoral students in biomedical engineering, within a multidisciplinary context that specifically engages clinicians and clinician-scientists towards that end. During their participation as trainees in their first two years of predoctoral study in the University of Minnesota (UMN)’s established biomedical engineering graduate program, six trainees per year will interact with a strong training faculty in numerous ways, including these distinctive activities beyond commencing their doctoral research:
- complete the courses Advanced Cardiac Physiology and Anatomy (organized by the leader of UMN-Medtronic Visible Heart Lab collaboration) and Cardiovascular Devices (taught by local cardiovascular device company experts);
- complete a clinical immersion in one of the UMN cardiovascular clinics;
- attend an innovation lecture series (offered through the UMN Medical Devices Center);
- attend monthly clinical focus lunches with invited clinicians presenting specific cardiovascular diseases and associated medical device limitations;
- and attend monthly professional development lunches with invited speakers addressing broad career opportunities including medtech company R&D, FDA, and patent law.
We will recruit a diverse group of trainees, and the program will be reviewed periodically by an advisory committee to ensure its success in all respects. We expect that the resulting multidisciplinary research and perspective of our trainees will enable them to meet the aforementioned demand by driving future technological advancements, either as R&D engineers at cardiovascular device companies, device regulators at federal labs, or as professors leading their own research programs in cardiovascular engineering.
Samuel Dudley, MD, PhD
Peter Crawford, MD, PhD
Program Scope and Mission – This Training Program in Cardiovascular Innovation is designed to teach the scientific and technical skills necessary to develop a novel idea and carry this idea through to proof-of-concept in man. The training program takes unique advantage of the strengths of the Lillehei Heart Institute (LHI), the University of Minnesota Cardiovascular Division, the wider community of translational medicine and entrepreneurship at the University of Minnesota, and the Twin Cities biotech, pharma, and device industries. This application trains basic and clinical scientists in an interdisciplinary environment with the goal of giving them the insight and tools to be able to successfully carry an idea from conception to implementation in man. Therefore, the major goal of this new Training Program is to provide an interdisciplinary research and training environment wherein trainees will be exposed to the continuum of technological development from conceptual idea to testing at the basic, small animal, large animal, and human levels. Trainees will be advantaged by community strengths in basic, translational, and clinical science, training in cardiovascular innovation and entrepreneurship, and industry interactions and mentorship. The combination of scientific and entrepreneurship training is the central innovative feature of this application.
John Spertus, MD, MPH
Missouri/Lauer Endowed Chair
Professor, University of Missouri-Kansas City
Clinical Director, Outcomes Research
Saint Luke’s Mid America Heart Institute
Program Scope and Mission – Applications are invited for a 2-year postdoctoral training program in cardiovascular outcomes research to begin July 1, 2018. This T32 training program, funded by the National Heart Lung and Blood Institute to the University of Missouri-Kansas City (UMKC), is hosted by Saint Luke’s Mid America Heart Institute (SLMAHI) in close collaboration with the University of Kansas.
The Full-Time Training Program offers:
• Advanced seminars of specialized skills for Outcomes Research
• Opportunity to obtain an MS in Bioinformatics with an emphasis in Clinical Research for those without prior formal training in the field
• Multidisciplinary mentorship, individualized to meet the needs of each Fellow
• Hands-on research experiences with access to highly experienced statisticians and numerous databases including multicenter outcome registries (e.g., PREMIER, TRIUMPH, PORTRAIT, PRISM, OPEN CTO, OPTIMUM), clinical trial databases (e.g., PARTNER, FREEDOM, SYNTAX), national quality databases (e.g., ACC’s National Cardiovascular Data Registries, AHA’s National Registry of Cardiopulmonary Resuscitation) and publically available clinical trial and observational data sets.
• Salaried position based on NIH postdoctoral stipend scales
• Insurance benefits, vacation time, tuition (for MS coursework), and funds for travel expenses to professional conference(s)
Jon Matsumura, MD
Sarah Pavao, Program Coordinator
Associate Administrative Program Specialist
Department of Surgery | University of Wisconsin School of Medicine and Public Health
K6/160 CSC | 600 Highland Avenue | Madison, WI 53792-1690
Program Scope and Mission – The University of Wisconsin Vascular Surgery Research Training Program is a multidisciplinary and collaborative program that will co-train young physician/surgeons who have chosen to be vascular specialists, along with PhD scientists who have a research interest in vascular disease. This NIH-funded program provides trainees with multiple opportunities for research activities in vascular-related research disciplines in order to foster the development of knowledge, skill, and experience for success in the future academic careers of our trainees. Our goal is to accelerate the performance of basic, translational and clinical research for vascular disease by producing future surgeons, scientists and engineers who will meet the great need for innovation in treatments for the growing population of patients.
Dr. Anjon Audhya
Molecular and Cellular Pharmacology
School of Medicine and Public Health
420 Henry Mall
Madison, WI 53706
Phone: (608) 262-3761
Kristin Cooper, MS
Molecular and Cellular Pharmacology
University of Wisconsin-Madison
Mail: Room 1005, 1111 Highland Ave
Madison, WI 53705
Phone: (608) 262-9826
Program Scope and Mission – Pharmacology is the knowledge of the biochemical and physiological actions of drugs, which act on cellular signaling pathways. The molecular basis of cellular signaling and its control by various drugs is a major aspect of modern pharmacology and this aspect is emphasized in the Molecular and Cellular Pharmacology Training Program. The majority of signal transduction pathways still await discovery or at least a thorough molecular characterization. Members of our program employ the whole spectrum of modern biochemical, cell and molecular biological, physiological, and pharmacological methods in a basic research-oriented scientific environment to unravel the many unsolved mysteries underlying cellular regulation and signaling. Certain research initiatives have a translational component, with the goal of applying basic discoveries to developing new therapeutic modalities.
Our program brings together an outstanding group of over 70 dedicated trainers with a focus on cellular signal transduction. Graduates of the program will be well prepared for a career in basic biomedical sciences in academia, industry, and more. We provide a unique training experience for young scientists who want to elucidate basic principles of cellular signal pathways. Detailed knowledge of these pathways is the most important prerequisite for the discovery of new drugs and the treatment of diseases. The members of the Molecular and Cellular Pharmacology Training Program invite you to examine the educational and research opportunities described on our website, and to consider joining this unique and exciting graduate program.
Program Scope and Mission – Our grant emphasizes pre-doctoral and post-doctoral training in the areas of vascular biology, and hematopoietic stem cells and malignancy. Vascular biology is critically important for human disease, impacting on basic processes such as inflammation, the immune response, hemostasis, thrombosis, and metastasis.
We have assembled a broad array of expertise in cellular and molecular aspects of hemostasis, extracellular matrix biology, vasculogenesis/angiogenesis, cellular mechanisms of inflammation, the genetics of diabetes, lipoprotein metabolism, and clinical aspects if hemophilic and thrombophilic states. Likewise, hematopoietic stem cells are important to therapeutic approaches in a variety of disease states, and the University of Wisconsin is an internationally recognized leader in embryonic stem cell biology. The participating investigators have expertise in the biology and hematopoietic differentiation of embryonic stem cells, chromatin modifications in hematopoiesis and leukemogenesis, intracellular signaling in myeloma, clinical trials in lymphoma, bone marrow transplantation, and clinical applications of embryonic stem cells in vascular and malignant disease. There is a strong emphasis on providing the multidisciplinary training required to pursue translational research opportunities, and the formal training of clinical investigators. Our training program takes advantage of the Clinical Investigator Preparatory Program (K30 grant) at the University of Wisconsin to provide didactic training in clinical trial design and biostatistics for candidates pursuing translational research projects.
Jian-Ping Jin, M.D., Ph.D.
Professor & William D. Traitel Endowed Chair
Wayne state University School of Medicine
Department of Physiology
Christine R. Cupps
Detroit Cardiovascular Training Program
Wayne State University
Department of Physiology
5278 Scott Hall
540 E. Canfield
Detroit, MI 48201
Program Scope and Mission – Cardiovascular disease is a leading cause of mortality in the United States. Understanding the physiology and pathology of the heart and circulation is the foundation for improving the treatment and prevention of cardiovascular diseases. The Detroit Cardiovascular Training Program (DCTP) was the first NIH-supported predoctoral training program in the region to provide research training for PhD graduate students in integrative and translational cardiovascular sciences. This training effort is contributing to the education of a new generation of scientists who will not only pursue cardiovascular research to improve health care, but also strengthen our economic base by innovations that will be translated to medical practice.
The DCTP has assembled an leading group of researchers from multiple departments such has Physiology, Biomedical Engineering, and Pharmaceutical Sciences, who provide expertise and research opportunities to trainees that range from molecular, cellular and organ levels to clinic research. In addition, Wayne State University has an outstanding track record of providing extensive training in the cardiovascular sciences and an exceptional record in the training of minority students in the Detroit metropolitan area, contributing a major role in research education in the region.
Director and Contact:
Jeanne M. Nerbonne, Ph.D.
Program Scope and Mission – The goals of the Integrative and Systems Biology of Cardiovascular Disease Training Program in the Center for Cardiovascular Research at Washington University are to provide predoctoral and postdoctoral trainees with: outstanding research opportunities; fundamental education and basic training in cardiovascular physiology, pathophysiology and disease mechanisms; opportunities to be introduced to and to participate in, translational cardiovascular research; and, mentoring to prepare them to be productive, independent scientists, educators and mentors. The critical components and the clear strengths of this Program are the twenty-one (23) participating faculty and the trainees themselves. Another clear strength of this Training Program is the highly interactive and collaborative environment in the Center for Cardiovascular Research, indeed at Washington University in general, which translates to expanded research, education, training and mentoring opportunities for all of our trainees. The participating training faculty derive from seven Departments, and includes nationally and internationally recognized leaders in the three research and training areas of emphasis in this Training Program: 1) Cardiac biology, remodeling and cardiomyopathies; 2) Ion channels, myocardial excitability and arrhythmias; and, 3) Vascular biology, inflammation and coronary disease. The participating faculty are all highly interactive, collaborative, productive, well-funded investigators who are committed to providing the training, experience, resources, intellectual enthusiasm, and mentoring needed to facilitate the scientific and professional development of the Program trainees. In addition, trainees in this Program participate in: a “Core Curriculum in Integrative and Systems Cardiovascular Biology”, with an continuing emphasis on Rigor and Reproducibility and the Responsible Conduct of Research; weekly "Trainees in Cardiovascular Biology" work in progress series; weekly “Cardiovascular Research” seminar series; biannual “Cardiovascular Training Program Distinguished Lectureship”; and “Cardiovascular Research Day”. This Training Program also provides trainees the opportunity to participate in translational cardiovascular research, and has developed and implemented formal and informal mechanisms to guide trainees in the formulation of individualized educational, training and career development plans and for monitoring the progress, professional development and mentoring of each predoctoral and postdoctoral trainee. Formal mechanisms are also in place for evaluating, and evolving as needed, the Training Program itself.
Currently listing programs from Cedars-Sinai Medical Center, Oregon Health and Science University, Stanford University, University of Arizona, University of California, Los Angeles, Unversity of California, San Diego, Unversity of California, San Francisco, University of Colorado, University of Hawai'i, University of New Mexico and the University of Washington
Eduardo Marbán, M.D., Ph.D.
Mark Siegel Family Foundation Distinguished Chair and Director of the Heart Institute
Director, Cedars-Sinai Smidt Heart Institute
Professor of Medicine and Physiology
Joshua I. Goldhaber, M.D.
Dorothy and E. Phillip Lyon Chair in Laser Research
Director, Basic Research Programs
Director, Cardiology Fellowship Program
Associate Director, Cardiac Intensive Care Unit
Director, Division of Applied Cell Biology & Physiology
Professor of Medicine
Program Scope and Mission – The objective of The Cedars-Sinai Smidt Heart Institute Institutional Training Program is to provide postdoctoral fellows with the necessary skills to develop independent and productive academic careers in cardiovascular science. We seek to ensure that all our trainees, be they PhDs, MDs, MD/PhDs or equivalent, develop an in-depth knowledge of the basic science underpinning clinically relevant problems in cardiovascular medicine, as well as a comprehensive understanding of rigorous study design, appropriate methodology and expert technical execution of basic and clinical studies. This not only provides clinical investigators with the skills they need to properly test hypotheses generated at the basic science level, but also informs basic scientists about the clinical aspects of disease in order to stimulate clinically relevant state-of-the-art investigations in the laboratory.
Our training program’s areas of research focus include Cardiac Biology, Arrhythmias, Vascular Biology and Atherosclerosis, Regenerative Medicine, Transplant Immunology, Cardiovascular Imaging, Women’s Health, Community Health, Implementation Science, Precision Medicine and Genetics. The Training Program takes full advantage of the unique strengths of Cedars-Sinai Medical Center (CSMC), the largest private teaching hospital west of the Mississippi, which has a longstanding commitment to translational research and to serving the local community. The Cedar Sinai Heart Institute (CSHI) houses the largest adult heart transplant program in the world, performed an NIH-funded first-in-human trial of cardiac-derived stem cell therapy, and has attracted many NIH-funded basic and translational investigators. Some of these share joint appointments in other CSMC units, which include the Regenerative Medicine Institute, Biomedical Imaging Research Institute, and the Departments of Biomedical Sciences, Medicine, and Pathology. Trainees receive an intensive research experience in a focused area of investigation, augmented by a formal curriculum that includes both basic and clinical seminars, instruction in grant and manuscript writing, public speaking, biostatistics and ethics. Several courses are provided by the Department of Biomedical Sciences, the CSMC Clinical Scholars Program, and a multi-campus NIH CTSA-supported Center for Translational Science Institute (CTSI, includes CSMC, UCLA, Harbor-UCLA, and Charles Drew University). The CTSI provides our trainees with privileged access to project seed funds, additional courses in clinical research design, and tools for conducting the entire range of studies from bench to bedside to community. In summary, we have designed a program that provides in-depth training in critical areas of cardiovascular science within an environment that champions translational research and clinical excellence.
Nabil J. Alkayed, MD, PhD
James Metcalfe Chair of Cardiovascular Medicine
Professor and Director of Research, Knight Cardiovascular Institute
Oregon Health & Science University
3181 S.W. Sam Jackson Park Road, Portland, Oregon 97239
Mail Code: UHN-2 ; Phone: 503.418.5502
Program Scope and Mission – http://www.navbo.info/OHSU2017-18.pdf.
Christopher Gardner, PhD
Alana Koehler, Fellowship Coordinator
Administrative Associate for Christopher Gardner, PhD
Stanford Prevention Research Center
1265 Welch Road, X3C06
Stanford, CA 94305-5411
Voice 650 723 7822
Fax 650 725 6247
Program Scope and Mission Postdoctoral Research Fellowship in Chronic Disease Prevention and Control. The Stanford Prevention Research Center, an interdisciplinary research program on the prevention of chronic disease, is seeking MD and PhD applicants for postdoctoral research fellowships for the academic year 2018-2019. Fellows gain direct research experience in cardiovascular disease prevention, community and health psychology, behavioral medicine, intervention methods, clinical epidemiology, research design, and biostatistics.
See also the website for additional details http://prevention.stanford.edu/education/fellowship/training.html
David L. M. Preston, M.A.
Cardiovascular Institute Program Manager
265 Campus Drive, G1120; MC-5454
Stanford, CA 94305
Program Scope and Mission - This program trains a total of six fellows over two years in the following areas of vascular medicine & research: Vascular Reactivity & Thrombosis, Vascular Regeneration & Development, Metabolic or Lifestyle Influences on Vascular Outcomes, Proteomic Markers & Genetic Determinants of Vascular Disease, Gender & Ethnicity Differences in Vascular Disease, and Vascular Bioengineering. Twenty-nine faculty mentors from eighteen different departments within the School of Medicine and the University provide a variety of angles from which to address fundamental questions about vascular disease. A structured curriculum, well-defined mentorship, and both internal and external evaluations ensure that fellows receive training in both research and career development to prepare them for independent careers. All fellows undergo a minimum two-year training period, with strong encouragement to submit individual research proposals (NRSA and AHA) for the following year(s). Support for a second year is conditional on evidence of research progress. At times a third year is offered for the transition to independence. It is mandatory that in Year 1 the trainee and mentor will outline a career plan for transition to independence, which may include grant preparations for funding through a K08 mechanism or application to the existing K12.
Joseph Wu, MD, PhD
Stanford University School of Medicine
ProfessorDirector, Stanford Cardiovascular Institute
Simon H. Stertzer, MD Professor of Medicine & Radiology
Lorry I. Lokey Stem Cell Research Building
265 Campus Drive, Rm G1120B
Stanford, CA 94305-5454
CVI Website: http://med.stanford.edu/cvi.html
Program Scope and Mission – The Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford is funded by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health. The program is designed to train the next generation of CV imaging investigators by exposing them to three complementary areas – clinical, engineering, and molecular imaging. With the impact of cardiovascular disease on US and world health and the rapid advances in imaging technologies and cardiovascular biology, it is critical that fellows be provided a broad, multi-disciplinary, and collaborative training program to foster their ability to translate CV imaging research into clinical application. Mentors from the Schools of Medicine and Engineering, including Cardiovascular Medicine, Radiology, Molecular Imaging, Electrical Engineering, and Bioengineering are available. For more details: http://med.stanford.edu/cvi/education/cardiovascular-imaging-t32.html
Jennifer K. Barton, Ph.D.
Director, BIO5 Institute
Professor, Biomedical Engineering
Professor, Optical Sciences
Professor, Agricultural-Biosystems Engineering
Professor, BIO5 Institute
Dr. Jennifer K. Barton
Program Scope and Mission – The Cardiovascular Biomedical Engineering training program is dedicated to training pre-doctoral students in both biological and engineering disciplines focusing on cardiovascular health to meet the demands of a growing biomedical engineering field.
This program takes advantage of the UA Department of Biomedical Engineering faculty's, and the Arizona industrial community's strong expertise in bioengineering and cardiovascular biology. Areas of expertise include biomechanics, biomaterials, optics, molecular genetics, vascular physiology, imaging, tissue engineering, genetic engineering and biocomputing.
Reza Ardehali, M.D., Ph.D.
Associate Professor of Medicine
Associate Chief of Cardiology, Regenerative Medicine
Advanced Heart Failure, Mechanical Circulatory Support and Transplantation
Division of Cardiology
Broad Stem Cell Research Center
UCLA School of Medicine
675 Charles E. Young Drive S. Rm 3780
Los Angeles, CA 90095
Sr. Admin Analyst
Division of Cardiology
Broad Stem Cell Research Center
UCLA School of Medicine
Program Scope and Mission - The main objective of the Vascular Biology Training Program is to develop the next generation of cardiovascular biologists. The program places a strong emphasis on creativity, networking and self-motivation to develop independent scientists who will make significant contributions to biomedical research and be an asset to the institutions and communities they serve.
To achieve these goals, we have developed a strong mentorship approach, novel didactic components and incorporated high exposure to medicine. UCLA houses a tremendous resource of interdisciplinary groups whose research focuses in vascular biology. The group includes 27 laboratories that currently offer training to 124 graduate students and postdoctoral fellows. It is this community that constitutes the pillars of a unique training program for the next generation of investigators in this area of research. The Program is funded by a grant from the NHLBI that supports pre- and post-doctoral trainees for three and two years respectively. The program also features a highly interactive seminar series with outside speakers and several seminar venues for discussion of science by trainees and UCLA investigators. We invite you to drive through the website and get to learn more about our program and recent accomplishments.
Matthew A. Allison, MD, MPH, FAHA
University of California San Diego
Professor and Interim Chief
Division of Preventive Medicine
Department of Family Medicine and Public Health
9500 Gilman Drive, Mailcode 0965
La Jolla, CA 92093-0965
Nova Barkley, T32 coordinator
9500 Gillman Drive, MC 0607
La Jolla, CA 92093-0607
Program Scope and Mission – http://cvdepit32.ucsd.edu.
Director and Contact:
Andrew D. McCulloch, Ph.D.
UC San Diego
Department of Bioengineering
9500 Gilman Ave. MC0412
La Jolla, CA 92093-0412
Program Scope and Mission – The aim of this program is to train pre-doctoral bioengineering graduate students to apply quantitative bioengineering approaches to study integrative cardiac, vascular and blood physiology and pathophysiology and to work with physicians on developing novel technologies for therapy and diagnosis of cardiovascular diseases. Trainees learn how to conduct interdisciplinary research by integrating: (a) the engineering and biomedical sciences; (b) across physical scales of biological structure from genes and molecules to tissues and organ-systems; (c) across interacting physiological systems and subsystems; and (d) basic research with technology innovation for clinical applications. Our goal is to train the next generation of bioengineering scientists to be leaders in innovative cardiovascular research and technology development to advance healthcare delivery and improve health outcomes. The program is especially well known for its leadership in systems biology, regenerative medicine and multi-scale bioengineering. Graduates have gone on to become leaders in research, industry and academia including department chairs of top programs.
Mark Howard Ginsberg, M.D.
Distinguished Professor, School of Medicine
9500 Gilman Drive, MC0726
La Jolla, CA 92093
Program Scope and Mission – Arterial thrombosis is frequently the proximate cause of death and morbidity in cardiovascular diseases. These diseases are the leading cause of death in the Western World. Formed elements of the blood and cells of the vessel wall play central roles in arterial thrombosis and in the arrest of bleeding. We have begun an interdisciplinary training program for postdoctoral scientists in the area of blood cells in hemostasis and thrombosis, based in the Division of Hematology-Oncology, to be a centerpiece in an Initiative in Vascular Biology at the University of California San Diego, La Jolla Campus.
Each faculty mentor is an internationally recognized investigator in the development and functioning of the cells that mediate thrombosis and has a strong track record of peer-reviewed research support and of training. The faculty has interacted extensively through the mechanisms of collaboration and through two program projects focused on Vascular Biology and Hemostasis-thrombosis. The interdisciplinary nature of the program is established by faculty primary appointments in six University departments including Cellular and Molecular Medicine, Biology, Pathology, Pharmacology, Physics and Medicine. The core of the program is through performance research in faculty laboratories spanning the disciplines of signal transduction, gene regulation, hematopoiesis, angiogenesis, and the molecular and cell biology of cells of the blood and vessel wall. The practical training will be complemented by didactic coursework in the conduct of research and in the writing of scientific manuscripts and grant applications. Furthermore, the trainees will attend a weekly conference in Atherosclerosis, Thrombosis, and Vascular Biology and will have the opportunity to participate in didactic hematology-oncology translational research conferences and in elective coursework offered throughout UC San Diego. This training program provides a unique interdisciplinary educational opportunity to mentor outstanding scientists for research careers in the cellular basis of hemostasis and thrombosis and will form the only active training program at UC San Diego directly devoted to this health-related field.
K. Mark Ansel, PhD
K. Mark Ansel, Ph.D.
Associate Professor, UCSF Department of Microbiology and Immunology
Investigator, Sandler Asthma Basic Research Center
Director, Biomedical Sciences Graduate Program
513 Parnassus Avenue, Box 0414, HSE-1001E
San Francisco, CA 94143-0414
Office: (415) 476-5368
Lab: (415) 476-5373
Fax: (415) 502-4995
Program Scope and Mission The Biomedical Sciences (BMS) Graduate Program at UCSF provides students with a wide range of opportunities for their development as researchers that investigate the function of tissue and organ systems in development, physiology and disease. The BMS program’s curriculum provides a foundation in molecular biology, biochemistry, cell biology and the investigation of human biology and disease, and is customized to thematic areas through innovative mini-courses, research rotations, thematic retreats, seminars and other events. Vascular & Cardiac Biology is one of the BMS program's major themes, with over 25 dedicated faculty that are world renowned experts in their respective fields. The program provides in depth interaction and access to the Cardiovascular Institute (CVRI) and the Gladstone Institute of Cardiovascular Disease, together comprising over 100 faculty members investigating a wide spectrum of basic science to disease-focused and patient-based research in cardiovascular biology and disease, as well as world-class core facilities, scientific seminars and research retreats.
Judith Hellman, MD
Research Administration Manager
Department of Anesthesia & Perioperative Care
3333 California Street, Suite 290
San Francisco, CA 94118
Program Scope and Mission The primary goal of the program is to provide rigorous training in the fundamentals and techniques of conducting research in areas of concern to clinical anesthesiology and the larger practice of medicine. The Vascular Biology and Bioengineering Track hosts faculty mentors from the Departments of Anesthesia, Biochemistry and Biophysics, Bioengineering, Cellular and Molecular Pharmacology, Medicine, Neurosurgery, Radiology & Biomedical Imaging, and Surgery. Among the broad range of topics studied are AVMs, stroke, vascular aneurysms, drug delivery across the blood brain barrier, spinal cord injury and repair, G-protein coupled receptors, PPARs, thrombosis, novel bioengineered therapeutic antibody development and biomedical imaging. Additional program tracks include Critical Care; Genomics, Outcomes Research and Bioinformatics; and Neuroscience, Pain and Addiction. Funded by the NIH/NIGMS since 1995, the T32 program supports 2 to 3-year trainee appointments, dependent on sufficient trainee progress. Applicants should be MD or MD/PhD scientists, and must be United States citizens, permanent residents or non-citizen nationals. UCSF has an exceptional commitment to excellence and diversity. We welcome all qualified applications and particularly encourage applications from members of underrepresented groups in the sciences, including underrepresented minorities, veterans, and individuals with disabilities. UCSF offers reasonable accommodations for qualified individuals with disabilities. If you are a person with a disability who would like to discuss potential accommodations or engage in a confidential conversation, please contact Disability Management Services at 415-476-2621. Applications are accepted on a continuous basis. For more information and application instructions, contact Claire Harmon at the address above, or visit the program website.
Kurt R. Stenmark, MD
Professor of Pediatrics and Medicine
Division Head, Pediatric Critical Care Medicine
Director, Developmental Lung Biology and
Cardiovascular Pulmonary Research Laboratories
Administrator, CVP Research
Program Scope and Mission The Cardiopulmonary and Vascular Biology Research Lab’s emphasis area integrates several well-established and successful programs and laboratories that utilize multidisciplinary approaches towards developing a greater understanding of basic mechanisms and therapies for the treatment of diverse cardiac, pulmonary and vascular diseases in newborns, infants and children.
The overall purpose of this group is to promote basic and translational research and to develop and apply novel strategies that will enhance outcomes of children with cardiopulmonary and vascular disorders. Key goals are to facilitate and co-ordinate new program development; provide an “academic home” that will create an environment to enhance mentorship, training and career development opportunities for students, residents, fellows and faculty; establish critical core laboratories to enhance patient- and laboratory-oriented research; expand educational opportunities through integrative seminars, courses and symposia; and to more effectively link investigators from diverse disciplines to encourage further development of novel programs based on principles of “team science.” This group incorporates strengths from current programs that link clinical care, clinical research, laboratory research, education and training. Current themes of ongoing clinical and laboratory research include: basic mechanisms of angiogenesis and vascular development; the influence of vascular growth on lung structure; epigenetic mechanisms of pulmonary vascular disease; the pathobiology of pulmonary hypertension, including vascular inflammation; roles of progenitor cells in vascular development, disease and therapies; novel assessments of right ventricular function, especially in the setting of pulmonary hypertension; the epidemiology and natural history of pulmonary vascular disease in preterm infants; clinical response to drug therapy in chronic pulmonary hypertension; and the development of novel vascular therapies to promote fetal health and prevent premature birth.
Dr. Ralph Shohet
Dr. Michelle Tallquist
Center for Cardiovascular Research
John A. Burns School of Medicine
651 Ilalo Street, BSB 311
Honolulu, HI 96813
Program Scope and Mission The Training in Cardiovascular Research program is an NHLBI funded T32 grant in the Center for Cardiovascular Research at the University of Hawaii. The goal is to provide predoctoral and postdoctoral trainees with a rigorous background in cardiovascular science and techniques that will enable continued success as independent, productive, and innovative researchers. At our new medical campus on the shores of Honolulu, fellows will investigate advanced topics in cardiovascular biology within modern laboratories and with use of state-of-the-art cores. The program consists of 19 University of Hawaii investigators and an additional 10 faculty from the Cardiovascular Institute at Stanford. The training program is designed to meet individual needs but has a common core focused on a comprehensive understanding of cardiovascular science including methodology, anatomy, physiology, and molecular biology. Highlights of the program include a structured mentor program, external project review, and a cardiovascular specific curriculum including journal clubs, problem based learning, and grant writing. Appointments are 1-2 years dependent on continued progress. All fellows are encouraged to obtain independent funding, and many past trainees have been successful in procuring their own fellowships. Applications are restricted to U.S. citizens or permanent residents. For more information, please contact the Program Deputy Director at the address above.
Thomas C. Resta, PhD
Professor and CRTP Director
Vascular Physiology Group
Dept. of Cell Biology and Physiology
1 University of New Mexico
Albuquerque, NM 87131-0001
Home Page: http://cbp.unm.edu/faculty-profiles/resta.html
Program Scope and Mission – The Cardiovascular Research Training Program (CRTP) at the University of New Mexico (UNM) Health Sciences Center (HSC) is funded by a T32 grant from the NIH National Heart Lung and Blood Institute (NHLBI). The goal of the CRTP is to provide exceptional pre- and post-doctoral trainees a broad, multidisciplinary background in cardiovascular and pulmonary research with integration between basic and clinical sciences. The CRTP partners with the interdisciplinary Biomedical Sciences Graduate Program (BSGP; http://hsc.unm.edu/research/BREP/graduate/bsgp/index.html) at the UNM HSC. This non-departmental program provides training for PhD students in biomedical sciences in the first year followed by in-depth training in the chosen discipline in subsequent years. A training program with a concentration in cardiovascular physiology is available for all predoctoral CRTP trainees in the BSGP. The CRTP T32 provides an NIH level stipend, and allowances for tuition and fees, health insurance, training-related expenses, and travel to scientific meetings. Appointments are 2-3 years for predoctoral students and 2 years for postdoctoral trainees, with subsequent support provided by individual training fellowships or mentored career awards. Applications are restricted to U.S. citizens or permanent residents. For more information and program application instructions, please contact the CRTP Program Director, Dr. Thomas Resta, at the address below.
Director and Contact:
Michael Regnier, PhD
Washington Research Foundation Professor of Bioengineering
Associate for Research, Department of Bioengineering
University of Washington
Seattle, WA 98109
Program Scope and Mission – The Bioengineering Cardiovascular Training Grant (BCTG) program provides an opportunity for predoctoral students interested in cardiovascular science and engineering to receive training support for their research under the guidance of excellent mentors. The program will simultaneously enrich the trainee’s research and strengthen the future of cardiovascular-related research and technology development in the United States.
The BCTG program is directed by Dr. Michael Regnier and a Steering Committee that selects trainees and monitors their training progress. Training support is usually provided for 2 years. Cardiovascular based research projects that involve collaboration between at least two research laboratories will be preferentially considered.
Participating departments include: Bioengineering, Biology, Chemical Engineering, Mechanical Engineering, Pathology, and Physiology & Biophysics. Predoctoral students from other departments may be considered. Students are eligible after being accepted into a laboratory and supported by the faculty mentor for at least one quarter. There are three main components of the training program:
1. Research in the laboratory of a BCTG faculty mentor on some aspect of cardiovascular physiology, pathology, development of therapeutic treatment, diagnostics and/or imaging.
2. A didactic component that includes a specialized course (Cardiac Bioengineering), a clinical cardiac imaging preceptorship, a seminar series that provides both broad-based knowledge and advanced concepts in focused areas, and a monthly journal club. Trainees with identified weaknesses in mathematics, engineering and/or integrative physiology will be strongly encouraged to do additional didactic training.
3. Communication and professional skills training by participation in seminar series, trainee seminars, and scientific writing programs. Emphasis is placed on career development, public speaking, manuscript preparation and writing fellowships or grant proposals (NIH, AHA, NSF, etc.) at the end of the training period.
Director and Contact:
Karin Bornfeldt, PhD
Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition
Associate Director, Diabetes and Obesity Center of Excellence
Deputy Director, Diabetes Research Center
University of Washington Medicine Diabetes Institute
UW Medicine Research
850 Republican Street, Box 358055
Seattle, WA 98109-4725
Program Scope and Mission Over-nutrition and obesity are major contributors to the cardiovascular disease epidemic in the United States and worldwide. A major reason for the increase in cardiovascular disease is the increasing prevalence of obesity in both adults and children. The rationale for the T32 Nutrition, Obesity and Atherosclerosis Training Program is to train new generations of postdoctoral MD clinicians and PhD scientists to tackle these problems, taking advantage of the broad interdisciplinary environment at the University of Washington.
The Nutrition, Obesity and Atherosclerosis Training Program’s overall goal is to provide a highly qualified and diverse group of postdoctoral MD clinicians and PhD scientists with the research skills they need to become fully independent biomedical investigators. The research supported by this training program centers on five themes, all related to increased risk of cardiovascular disease. The areas of focus are: i) Central obesity and its relationship to nutrition, dyslipidemia, and other cardiovascular risk factors. This theme includes both basic science and clinical studies of the mechanisms responsible for inflammation and other components of the metabolic syndrome, particularly central obesity. ii) Dyslipidemia and atherosclerosis. This theme includes studies of mechanisms, disorders, and other factors that lead to dyslipidemia, including the metabolic syndrome and diabetes. Mechanisms by which dyslipidemia influences events in the artery wall is an additional component. iii) Pathogenesis of atherosclerosis. This research investigates the pathogenesis of atherosclerosis, using isolated vascular cells and genetically engineered mice. Mouse models that overproduce or are deficient in proteins that modulate lipoprotein profiles are frequently studied. iv) Immunity in cardiovascular disease. This newly added theme studies the interrelationship among immunity, nutritional factors, obesity, and atherosclerosis both in humans and mouse models. v) Genetic and nutritional factors in cardiovascular disease. Several genetic and nutritional factors, including dietary lipids, contribute to the pathogenesis of atherosclerosis and are important in lipid disorders and inflammation. Both basic and clinical studies of the mechanisms by which genetic and nutritional factors play a role in cardiovascular disease support this theme. All of these are strong areas for both basic science and translational research emphasis at the University of Washington. In addition, each area offers our fellows numerous opportunities to acquire the multidisciplinary skills and knowledge that are essential for success in biomedical research. These areas were also chosen because they offer particularly ripe opportunities for integrating basic science and clinical medicine. This integration is essential for ensuring that today’s basic discoveries are translated into tomorrow’s clinical trials and therapies.